Cilnidipine and Olmesartan Medoxomil Tablets (10mg+20mg)

Cilnidipine and Olmesartan Medoxomil Tablets (10mg+20mg) Technical Specification:

GENERIC NAME OF THE MEDICINAL PRODUCT:

• Cilnidipine and Olmesartan Medoxomil Tablets (10MG+20MG)

QUALITATIVE AND QUANTITATIVE COMPOSITION:

• Cilnidipine and Olmesartan Medoxomil Tablets (10MG+20MG)
  Each film coated tablet contains:
  Cilnidipine IP………………………………………10mg
  Olmesartan Medoxomil IP……………………….20mg
  Colours: Ferric Oxide Yellow USP-NF and Titanium
  Dioxide IP

THERAPEUTIC INDICATIONS:

Olmesartan Medoxomil + Chlorthalidone is used in the treatment of Hypertension (high blood pressure). Olmesartan Medoxomil + Chlorthalidone is a combination of two medicines: Olmesartan and chlorthalidone which lower blood pressure effectively. Olmesartan is an angiotensin receptor blocker (ARB).

CAUTION & WARNING:

CAUTION: Read enclosed leaflet before use.
Keep medicine out of reach of children.
Tablet to be swallowed as a whole, and not to be chewed or crushed.

WARNING: WHEN PREGNANCY IS DETECTED, TELMISARTAN SHOULD BE DISCONTINUED AS SOON AS POSSIBLE AS IT CAN CAUSE INJURY AND EVEN DEATH TO THE DEVELOPING FETUS WHEN USED DURING SECOND AND THIRD TRIMESTERS OF PREGNANCY.

WARNING: To be sold by retail on the prescription of a Registered Medical Practitioner only.

CAUTION: It is dangerous to take this preparation except under medical supervision.

STORAGE & DOSAGE:

Storage: Store at temperature not exceeding 25℃.
Store in cool, dry & dark place.
Protect from Light & moisture.

Dosage: As directed by the Physician.

Introduction to Cilnidipine and Olmesartan Medoxomil Tablets (10mg+20mg)

Cilnidipine and Olmesartan Medoxomil Tablets (10mg+20mg) are a potent combination used in the treatment of hypertension (high blood pressure), a condition affecting millions worldwide. Uncontrolled high blood pressure is a leading cause of heart disease, stroke, and kidney complications.

This combination combines Cilnidipine, a calcium channel blocker (CCB), and Olmesartan Medoxomil, an angiotensin receptor blocker (ARB). Cilnidipine relaxes blood vessels to improve blood flow, while Olmesartan blocks angiotensin II, preventing blood vessel constriction. This dual action reduces the heart’s workload, improves cardiac efficiency, and helps maintain healthy blood pressure levels.

Globally, there is a growing demand for effective hypertension medications like Cilnidipine and Olmesartan Medoxomil Tablets (10mg+20mg) due to increasing cardiovascular disease prevalence, lifestyle changes, and aging populations. India, with its advanced pharmaceutical industry, has become a prime source of high-quality, cost-effective formulations for international buyers.

In-depth Details for Importers, Exporters, and Buyers

Taj Pharma, a leading Cilnidipine and Olmesartan Medoxomil Tablets (10mg+20mg) manufacturer in India, ensures that global importers receive premium-quality products with complete regulatory support.

✅ Regulatory Documentation Provided

• WHO-GMP Certification for manufacturing compliance

• EU-GMP approval for exports to regulated markets

• Certificate of Pharmaceutical Product (COPP)

• CTD / ACTD Dossier for regulatory submission

• Free Sale Certificate (FSC) for international marketing

• Certificate of Analysis (COA) for each batch

• Stability data in accordance with ICH guidelines

✅ Custom Packaging & Labeling

• Alu-Alu blister packs, HDPE bottles, and unit-dose packs

• Multi-lingual labeling to meet country-specific regulations

• Private labeling and customized branding options

• Tamper-evident and export-compliant packaging

✅ Shelf-life, Storage & Dosage Form

• Dosage Form: Tablet

• Strength: 10mg Cilnidipine + 20mg Olmesartan Medoxomil

• Shelf-life: 24–36 months

• Storage: Keep below 30°C, in a dry place, away from sunlight

✅ Export Certifications

• WHO-GMP certified production facility

• EU-GMP approved for regulated markets

• USFDA-compliant processes

• PIC/S and ICH guideline adherence

✅ Target Countries & Export Markets

Taj Pharma exports Cilnidipine and Olmesartan Medoxomil Tablets (10mg+20mg) to over 70 countries, including:

• Europe: UK, Germany, France, Italy

• Asia-Pacific: Vietnam, Malaysia, Thailand, Philippines

• Africa: Nigeria, Kenya, South Africa, Ghana

• Middle East: UAE, Saudi Arabia, Oman, Iraq

• Latin America: Brazil, Mexico, Chile, Peru

Why is the Most Trusted Manufacturer/Supplier/Exporter

Taj Pharma is recognized as the top Cilnidipine and Olmesartan Medoxomil Tablets (10mg+20mg) manufacturer in India due to its commitment to quality, global compliance, and affordability.

🌟 State-of-the-Art Manufacturing

• WHO-GMP and EU-GMP-certified facilities in Vapi, Gujarat

• Advanced, automated production lines with minimal contamination

• Dedicated QC and QA teams ensuring uniformity and reliability

🌟 Affordable Pricing & Quality Assurance

• Cost-effective pricing for bulk buyers

• Adherence to USP, BP, EP, IP pharmacopoeia standards

• Comprehensive quality control from raw material to finished product

🌟 Global Presence & Supply Chain Support

• International logistics and warehousing capabilities

• Timely delivery to regulated and semi-regulated markets

• Complete support for import/export documentation

🌟 Top 20 Countries Exporting

1. UK

2. Germany

3. France

4. Italy

5. Vietnam

6. Philippines

7. Thailand

8. Malaysia

9. Nigeria

10. Kenya

11. South Africa

12. UAE

13. Saudi Arabia

14. Oman

15. Iraq

16. Brazil

17. Mexico

18. Chile

19. Peru

20. Ghana

Common Side Effects & Safety Information

While Cilnidipine and Olmesartan Medoxomil Tablets (10mg+20mg) are generally well-tolerated, some side effects may occur:

• Feeling dizzy or tired

• Headaches, flu-like symptoms, runny or stuffy nose, cough

• Pain in back, bones, or joints

• Nausea, indigestion, or stomach ache

• Diarrhoea

• Swelling of feet, ankles, legs, or hands (oedema)

• Urinary tract infection (UTI)

Special Precautions:

• Olmesartan may cause kidney damage; consult your healthcare provider immediately if symptoms appear.

• Hyperkalemia (high potassium level) is a potential risk; avoid potassium supplements, potassium-rich foods, and salt substitutes unless directed by a physician.

Technical Product Specification Table

Pharmaceutical distributors, hospitals, and healthcare organizations seeking a trusted Cilnidipine and Olmesartan Medoxomil Tablets (10mg+20mg) manufacturer & supplier in India can partner with Taj Pharma.

📞 Contact Taj Pharma Today to secure bulk supplies for your market.
🌍 Visit: www.tajpharma.com

Top 20 FAQs

Q1: What are Cilnidipine and Olmesartan Medoxomil Tablets used for?
A1: They are prescribed for the treatment of hypertension (high blood pressure).

Q2: Who is the leading manufacturer in India?
A2: Taj Pharma, based in Vapi, Gujarat.

Q3: How do these tablets work?
A3: Cilnidipine relaxes blood vessels, and Olmesartan blocks angiotensin II, reducing blood pressure.

Q4: Are there any common side effects?
A4: Dizziness, headaches, flu-like symptoms, gastrointestinal discomfort, edema, and urinary tract infections.

Q5: Can these tablets affect kidneys?
A5: Olmesartan can cause kidney damage; regular monitoring is advised.

Q6: Should potassium intake be limited?
A6: Yes, avoid potassium supplements, high-potassium foods, and salt substitutes unless directed by your doctor.

Q7: Can these tablets be taken with other anti-hypertensive medications?
A7: Only under medical supervision; combination therapy may be required.

Q8: What is the shelf-life?
A8: 24–36 months, depending on storage conditions.

Q9: Are these tablets available for PCD Pharma Franchise?
A9: Yes, Taj Pharma offers nationwide PCD Pharma Franchise opportunities.

Q10: How are they packaged for export?
A10: Alu-Alu blister packs, HDPE bottles, and unit-dose packs with multi-lingual labeling.

Q11: What are the storage conditions?
A11: Store below 30°C, in a dry, cool place away from sunlight.

Q12: Is this combination therapy more effective than monotherapy?
A12: Yes, it provides better blood pressure control than either Cilnidipine or Olmesartan alone.

Q13: Can pregnant women take these tablets?
A13: Consult a doctor; ARBs are generally avoided during pregnancy.

Q14: Can this medicine prevent heart disease?
A14: Primarily used for blood pressure management; it may reduce cardiovascular risk indirectly.

Q15: Is Taj Pharma WHO-GMP certified?
A15: Yes, all products are WHO-GMP and EU-GMP compliant.

Q16: How quickly do these tablets work?
A16: Blood pressure reduction may be observed within 2–4 weeks of consistent use.

Q17: Are there any food restrictions?
A17: Avoid high-potassium foods if directed by your physician.

Q18: Can these tablets cause electrolyte imbalance?
A18: Yes, hyperkalemia is a potential risk.

Q19: Can they be exported to regulated markets?
A19: Yes, Taj Pharma exports to Europe, USA, Africa, Middle East, and Asia-Pacific.

Q20: Why choose Taj Pharma for Cilnidipine and Olmesartan Medoxomil Tablets?
A20: Premium quality, WHO-GMP compliance, competitive pricing, and reliable global supply.